Date:September 08, 2012

Brigitta Mueller, M.D., C.P.E., M.H.C.M.

Brigitta Mueller, M.D., M.H.C.M.Professor
Department of Pediatrics
Section of Hematology-Oncology
Baylor College of Medicine

Clinic Chief and Director,
Division of Clinical Operations, Quality and Safety
Texas Children’s Cancer and Hematology Centers

Dr. Brigitta Mueller
1102 Bates Street, Suite 1570
Houston, TX 77030

Phone: 832-822-4215
Fax: 832-825-9055
Email: bumuelle@txch.org


Dr. Brigitta Mueller is the Director, Division of Clinical Operations, Quality and Safety, at Texas Children’s Cancer and Hematology Centers.

Dr. Mueller’s interests are in the study of the pathogenesis of sickle cell disease, and the development of new therapies to lessen or cure this disease.  She is the principal investigator for several drug studies to treat sickle cell disease. Dr. Brigitta Mueller is also interested in the treatment of children with cancer or hematological problems in resource-limited countries, in all aspects of patient safety and in the development of efficient and family-friendly care.


M.D., Medical School of the University of Bern, Switzerland
M.H.C.M., Harvard School of Public Health
Residency, Children’s Hospital of the University of Bern, Switzerland and Boston Children’s Hospital
Fellowship, National Cancer Institute, NIH

Board Certifications

American Board of Pediatrics
American Board of Pediatrics Hematology/Oncology

Selected Memberships

Associate Member, Children’s Oncology Group (COG)
Fellow, American Academy of Pediatrics (AAP)
Member, American Society of Hematology (ASH)
Member, American Society for Pediatric Hematology/Oncology (ASPHO)
Member, Medical Advisory Board, Cooley’s Anemia Foundation

Clinical Special Interests

Hematologic Disorders
Sickle Cell Disease and Thalassemia
Error prevention, safety issues

Research Interests

Research Interests
Pathogenesis of sickle cell disease
Development of new therapies
Low resource countries
Patient safety
Development of efficient and family-friendly care